Abstract:Oral cancer is the sixth most common cancer type in the world, and 90% of it is represented by oral squamous cell carcinoma (OSCC). Despite progress in preventive and therapeutic strategies, delay in OSCC diagnosis remains one of the major causes of high morbidity and mortality; indeed the majority of OSCC has been lately identified in the advanced clinical stage (i.e., III or IV). Moreover, after primary treatment, recurrences and/or metastases are found in more than half of the patients (80% of cases within the first 2 years) and the 5-year survival rate is still lower than 50%, resulting in a serious issue for public health. Currently, histological investigation represents the "gold standard" of OSCC diagnosis; however, recent studies have evaluated the potential use of non-invasive methods, such as "liquid biopsy," for the detection of diagnostic and prognostic biomarkers in body fluids of oral cancer patients. Saliva is a biofluid containing factors such as cytokines, DNA and RNA molecules, circulating and tissue-derived cells, and extracellular vesicles (EVs) that may be used as biomarkers; their analysis may give us useful information to do early diagnosis of OSCC and improve the prognosis. Therefore, the aim of this review is reporting the most recent data on saliva biomarker detection in saliva liquid biopsy from oral cancer patients, with particular attention to circulating tumor DNA (ctDNA), EVs, and microRNAs (miRNAs). Our results highlight that saliva liquid biopsy has several promising clinical uses in OSCC management; it is painless, accessible, and low cost and represents a very helpful source of diagnostic and prognostic biomarker detection. Even if standardized protocols for isolation, characterization, and evaluation are needed, recent data suggest that saliva may be successfully included in future clinical diagnostic processes, with a considerable impact on early treatment strategies and a favorable outcome.

Emerging Technologies for Salivaomics in Cancer Detection

Emerging technologies for salivaomics in cancer detection.

Clinical validity of saliva and novel technology for cancer detection

Multifunctional Aunps@Hrp@Femof Immune Scaffold with a Fully Automated Saliva Analyzer for Oral Cancer Screening

Saliva Liquid Biopsy for Point-Of-Care Applications

Salivaomics, Saliva-Exosomics, and Saliva Liquid Biopsy

Leveraging Saliva for Insights into Head and Neck Cancer

Salivary Biomarkers for Oral Squamous Cell Carcinoma Diagnosis and Follow-Up: Current Status and Perspectives

Saliva-Based Biomarkers in Oral Squamous Cell Carcinoma Using OMICS Technologies: A Systematic Review

Salivary biomarkers in non-invasive oral cancer diagnostics: a comprehensive review

Saliva as a potential non-invasive liquid biopsy for early and easy diagnosis/prognosis of head and neck cancer

Review Insights on Salivary Proteomics Biomarkers in Oral Cancer Detection and Diagnosis

Saliva - a new opportunity for fluid biopsy

Scientific frontiers: emerging technologies for salivary diagnostics

Emerging salivary biomarkers by mass spectrometry.

Salivaomics in head and neck cancer

Salivary Metabolomics for Oral Cancer Detection: A Narrative Review

Label-Free SERS and MD Analysis of Biomarkers for Rapid Point-of-Care Sensors Detecting Head and Neck Cancer and Infections

Saliva in the diagnosis of diseases

Development of Transcriptomic Biomarker Signature in Human Saliva to Detect Lung Cancer